Nos publications
Platform technology for introducing liquid solubilizers in tablet formulations
AAPS - oct 2024
Lipid-based excipients, which are often liquid at room temperature, can enhance solubility and permeation. This study aims to incorporate a liquid lipid excipient into a solid dosage form for the poorly water-soluble drug ondansetron hydrochloride dihydrate (OHD).
Gelucire® 48/16: a safe wetting agent for tablet. A case study with fenofibrate
CRS Annual Meeting – Montreal (Canada) - jui 2022
Gelucire 48/16®: A Versatile Non-Ionic Solid Solubilizer for Tablets of Poorly Water-Soluble Drugs
AAPS PharmSci360 – Washington DC (USA) - nov 2018
A solid dispersion of ticagrelor and Gelucire® 48/16 is prepared to increase drug solubility . The solid dispersion is converted into tablets. The formulated tablets showed improved dissolution rate compared to the market reference.
Gelucire 48/16®: A Non-Ionic Solid Surfactant for Solubility Enhancement of Poorly Soluble Drugs
AAPS Annual Meeting & Exposition – San Diego (USA) - nov 2017
Macrogol esters: Influence on in vitro and in vivo dissolution of a poorly soluble drug
AAPS Annual Meeting & Exposition – San Diego (USA) - nov 2017
Gelucire® 48/16: a solid surfactant for tablets
Pharma Times, Vol. 48 – N° 11 – pp 17-22 - nov 2016
This article describes Gelucire® 48/16 – a novel pegylated lipid excipient, and its use as a solid surfactant for solubility enhancement.